As a result, dose adjustment in individuals with renal insufficiency or ESRD may be expected (Desk three and Desk 12). Decreasing the dose lowers peak serum drug concentrations and may compromise treatment efficacy. Based on professional belief, the interval concerning drug doses in individuals with a creatinine clearance of 30 mL/min creatinine cl